%0 Journal Article
%T Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus
%A Akira Yoshida
%A Fumio Miyamoto
%A Hideaki Jinnouchi
%A Hiroyuki Nishimura
%A Katsunori Jinnouchi
%A Keizo Kajiwara
%A Kunio Hieshima
%A Motoko Tanaka
%A Noboru Kurinami
%A Seigo Sugiyama
%A Tomio Jinnouchi
%A Tomoko Suzuki
%J Journal of Clinical Medicine Research
%D 2018
%R https://doi.org/10.14740/jocmr3419w
%X Background: We examined whether the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin can improve urine albumin-to-creatinine ratio (UACR) associated with a reduction in body weight or body fat in patients with type 2 diabetes mellitus (T2DM).
%U https://www.jocmr.org/index.php/JOCMR/article/view/3419